U.S., Feb. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07381751) titled 'Artificial Intelligence-assisted MDS-UPDRS Assessment for Parkinson's Disease' on Jan. 13.
Brief Summary: Idiopathic Parkinson's disease (PD) is a neurodegenerative disease that progressively causes both motor and non-motor symptoms. As the second most common neurodegenerative disease and most common movement disorder, it affects over 8.5 million people worldwide and 13,000 people in Hong Kong. The most classical symptoms of PD are resting tremors, rigidity of the muscles, bradykinesia (slowing of movement), and gait difficulty. Other symptoms include sleep disorders, psychiatric symptoms, cognitive impairment, and autonomic dysfunct...